Neogen Corporation Increase (Decrease) in Inventories
Neogen Corporation (NEOG) reported Increase (Decrease) in Inventories of -$38.20 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-30
- Neogen Corporation increase (decrease) in inventories for the quarter ending 2026-05-31 was -$16.70M.
- Neogen Corporation increase (decrease) in inventories for the quarter ending 2026-02-28 was -$4.79M, a 162.26% decline year-over-year.
- Neogen Corporation increase (decrease) in inventories for the quarter ending 2025-11-30 was -$18.66M, a 350.21% decline year-over-year.
- Neogen Corporation increase (decrease) in inventories for the quarter ending 2025-08-31 was $1.96M, a 80.30% decline year-over-year.
- Neogen Corporation increase (decrease) in inventories for fiscal 2026 was -$38.20M, a 337.27% decline from fiscal 2025.
- Neogen Corporation increase (decrease) in inventories for fiscal 2025 was $16.10M, a 71.20% decline from fiscal 2024.
- Neogen Corporation increase (decrease) in inventories for fiscal 2024 was $55.90M.
- Neogen Corporation increase (decrease) in inventories for fiscal 2023 was -$9.96M, a 147.24% decline from fiscal 2022.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-05-31 | -$16.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$21.50M derived: sum of 2 quarters · filed 2026-07-30 | -$40.16M derived: sum of 3 quarters · filed 2026-07-30 | -$38.20M 10-K · filed 2026-07-30 | ||
| 2026-02-28 | -$4.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | -$23.46M derived: sum of 2 quarters · filed 2026-04-09 | -$21.50M 10-Q · filed 2026-04-09 | -$30.50M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-11-30 | -$18.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | -$16.70M 10-Q · filed 2026-01-08 | -$25.70M derived: sum of 3 quarters · filed 2026-07-30 | -$18.00M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-08-31 | $1.96M 10-Q · filed 2025-10-09 | -$7.04M derived: sum of 2 quarters · filed 2026-07-30 | $660.00K derived: sum of 3 quarters · filed 2026-07-30 | $8.12M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-05-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$1.30M derived: sum of 2 quarters · filed 2026-07-30 | $6.16M derived: sum of 3 quarters · filed 2026-07-30 | $16.10M 10-K · filed 2026-07-30 | $16.12M 10-K · filed 2025-07-30 | |
| 2025-02-28 | $7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $15.16M derived: sum of 2 quarters · filed 2026-04-09 | $25.10M 10-Q · filed 2026-04-09 | $25.12M 10-Q · filed 2025-04-09 | $32.34M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | $7.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $17.40M 10-Q · filed 2026-01-08 | $24.64M derived: sum of 3 quarters · filed 2026-07-30 | $47.37M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-08-31 | $9.94M 10-Q · filed 2025-10-09 | $17.18M derived: sum of 2 quarters · filed 2026-07-30 | $39.91M derived: sum of 3 quarters · filed 2026-07-30 | $59.53M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2024-05-31 | $7.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $29.97M derived: sum of 2 quarters · filed 2026-07-30 | $49.60M derived: sum of 3 quarters · filed 2026-07-30 | $55.90M 10-K · filed 2026-07-30 | $55.95M 10-K · filed 2024-07-30 | |
| 2024-02-29 | $22.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | $42.36M derived: sum of 2 quarters · filed 2025-04-09 | $48.66M 10-Q · filed 2025-04-09 | $38.05M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-11-30 | $19.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-15 | $25.93M 10-Q · filed 2025-01-15 | $15.32M derived: sum of 3 quarters · filed 2025-07-30 | $22.45M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-08-31 | $6.30M 10-Q · filed 2024-10-10 | -$4.31M derived: sum of 2 quarters · filed 2025-07-30 | $2.83M derived: sum of 3 quarters · filed 2025-07-30 | -$11.98M derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-05-31 | -$10.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | -$3.48M derived: sum of 2 quarters · filed 2025-07-30 | -$18.29M derived: sum of 3 quarters · filed 2025-07-30 | -$9.96M 10-K · filed 2025-07-30 | ||
| 2023-02-28 | $7.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | -$7.67M derived: sum of 2 quarters · filed 2024-04-09 | $656.00K 10-Q · filed 2024-04-09 | $9.77M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-11-30 | -$14.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$6.48M 10-Q · filed 2024-01-09 | $2.64M derived: sum of 3 quarters · filed 2024-07-30 | $7.67M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-08-31 | $8.33M 10-Q · filed 2023-10-10 | $17.45M derived: sum of 2 quarters · filed 2024-07-30 | $22.47M derived: sum of 3 quarters · filed 2024-07-30 | $27.54M derived: sum of 4 quarters · filed 2024-07-30 | ||
| 2022-05-31 | $9.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $14.14M derived: sum of 2 quarters · filed 2024-07-30 | $19.21M derived: sum of 3 quarters · filed 2024-07-30 | $21.07M 10-K · filed 2024-07-30 | ||
| 2022-02-28 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | $10.09M derived: sum of 2 quarters · filed 2023-04-04 | $11.96M 10-Q · filed 2023-04-04 | $12.83M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-11-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $6.93M 10-Q · filed 2023-01-09 | $7.81M derived: sum of 3 quarters · filed 2023-08-15 | $8.54M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-08-31 | $1.86M 10-Q · filed 2022-09-30 | $2.74M derived: sum of 2 quarters · filed 2023-08-15 | $3.48M derived: sum of 3 quarters · filed 2023-08-15 | -$1.91M derived: sum of 4 quarters · filed 2023-08-15 | ||
| 2021-05-31 | $878.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $1.61M derived: sum of 2 quarters · filed 2023-08-15 | -$3.77M derived: sum of 3 quarters · filed 2023-08-15 | -$2.45M 10-K · filed 2023-08-15 | ||
| 2021-02-28 | $735.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | -$4.65M derived: sum of 2 quarters · filed 2022-04-01 | -$3.33M 10-Q · filed 2022-04-01 | $4.45M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-11-30 | -$5.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-30 | -$4.06M 10-Q · filed 2021-12-30 | $3.71M derived: sum of 3 quarters · filed 2022-07-27 | $5.84M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-08-31 | $1.32M 10-Q · filed 2021-09-30 | $9.09M derived: sum of 2 quarters · filed 2022-07-27 | $11.23M derived: sum of 3 quarters · filed 2022-07-27 | $9.20M derived: sum of 4 quarters · filed 2022-07-27 | ||
| 2020-05-31 | $7.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $9.91M derived: sum of 2 quarters · filed 2022-07-27 | $7.88M derived: sum of 3 quarters · filed 2022-07-27 | $10.01M 10-K · filed 2022-07-27 | ||
| 2020-02-29 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | $106.00K derived: sum of 2 quarters · filed 2021-03-31 | $2.24M 10-Q · filed 2021-03-31 | $3.93M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-11-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | $103.00K 10-Q · filed 2020-12-29 | $1.79M derived: sum of 3 quarters · filed 2021-07-30 | $6.75M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-08-31 | $2.13M 10-Q · filed 2020-09-30 | $3.82M derived: sum of 2 quarters · filed 2021-07-30 | $8.78M derived: sum of 3 quarters · filed 2021-07-30 | $9.63M derived: sum of 4 quarters · filed 2021-07-30 | ||
| 2019-05-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | $6.65M derived: sum of 2 quarters · filed 2021-07-30 | $7.50M derived: sum of 3 quarters · filed 2021-07-30 | $10.44M 10-K · filed 2021-07-30 | ||
| 2019-02-28 | $4.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $5.80M derived: sum of 2 quarters · filed 2020-04-03 | $8.74M 10-Q · filed 2020-04-03 | $7.53M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-11-30 | $847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | $3.79M 10-Q · filed 2019-12-27 | $2.58M derived: sum of 3 quarters · filed 2020-07-30 | $6.22M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-08-31 | $2.94M 10-Q · filed 2019-09-26 | $1.73M derived: sum of 2 quarters · filed 2020-07-30 | $5.37M derived: sum of 3 quarters · filed 2020-07-30 | $5.31M derived: sum of 4 quarters · filed 2020-07-30 | ||
| 2018-05-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $2.43M derived: sum of 2 quarters · filed 2020-07-30 | $2.37M derived: sum of 3 quarters · filed 2020-07-30 | $2.65M 10-K · filed 2020-07-30 | ||
| 2018-02-28 | $3.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | $3.58M derived: sum of 2 quarters · filed 2019-03-29 | $3.86M 10-Q · filed 2019-03-29 | $1.37M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-11-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | $218.00K 10-Q · filed 2018-12-28 | -$2.27M derived: sum of 3 quarters · filed 2019-07-30 | -$775.00K derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-08-31 | $276.00K 10-Q · filed 2018-10-05 | -$2.21M derived: sum of 2 quarters · filed 2019-07-30 | -$717.00K derived: sum of 3 quarters · filed 2019-07-30 | $1.34M derived: sum of 4 quarters · filed 2019-07-30 | ||
| 2017-05-31 | -$2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | -$993.00K derived: sum of 2 quarters · filed 2019-07-30 | $1.06M derived: sum of 3 quarters · filed 2019-07-30 | $6.97M 10-K · filed 2019-07-30 | ||
| 2017-02-28 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | $3.55M derived: sum of 2 quarters · filed 2018-03-29 | $9.46M 10-Q · filed 2018-03-29 | $6.12M derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-11-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $7.96M 10-Q · filed 2018-01-05 | $4.62M derived: sum of 3 quarters · filed 2018-07-27 | $8.61M derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-08-31 | $5.91M 10-Q · filed 2017-09-29 | $2.57M derived: sum of 2 quarters · filed 2018-07-27 | $6.55M derived: sum of 3 quarters · filed 2018-07-27 | $12.03M derived: sum of 4 quarters · filed 2018-07-27 | ||
| 2016-05-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27 | $643.00K derived: sum of 2 quarters · filed 2018-07-27 | $6.12M derived: sum of 3 quarters · filed 2018-07-27 | $9.43M 10-K · filed 2018-07-27 | ||
| 2016-02-29 | $3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | $9.46M derived: sum of 2 quarters · filed 2017-03-31 | $12.77M 10-Q · filed 2017-03-31 | $9.28M derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-11-30 | $5.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | $8.78M 10-Q · filed 2016-12-29 | $5.29M derived: sum of 3 quarters · filed 2017-07-28 | $6.40M derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-08-31 | $3.31M 10-Q · filed 2016-09-30 | -$180.00K derived: sum of 2 quarters · filed 2017-07-28 | $925.00K derived: sum of 3 quarters · filed 2017-07-28 | -$942.00K derived: sum of 4 quarters · filed 2017-07-28 | ||
| 2015-05-31 | -$3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | -$2.38M derived: sum of 2 quarters · filed 2017-07-28 | -$4.25M derived: sum of 3 quarters · filed 2017-07-28 | -$319.00K 10-K · filed 2017-07-28 | ||
| 2015-02-28 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | -$762.00K derived: sum of 2 quarters · filed 2016-03-31 | $3.17M 10-Q · filed 2016-03-31 | $2.64M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-11-30 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $2.07M 10-Q · filed 2016-01-08 | $1.53M derived: sum of 3 quarters · filed 2016-07-29 | $1.88M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-08-31 | $3.93M 10-Q · filed 2015-09-30 | $3.40M derived: sum of 2 quarters · filed 2016-07-29 | $3.74M derived: sum of 3 quarters · filed 2016-07-29 | $4.25M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-05-31 | -$531.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$189.00K derived: sum of 2 quarters · filed 2016-07-29 | $322.00K derived: sum of 3 quarters · filed 2016-07-29 | $3.53M 10-K · filed 2016-07-29 | ||
| 2014-02-28 | $342.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | $853.00K derived: sum of 2 quarters · filed 2015-04-01 | $4.06M 10-Q · filed 2015-04-01 | $1.29M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-11-30 | $511.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | $3.72M 10-Q · filed 2014-12-30 | $949.00K derived: sum of 3 quarters · filed 2015-07-30 | $3.72M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-08-31 | $3.21M 10-Q · filed 2014-09-30 | $438.00K derived: sum of 2 quarters · filed 2015-07-30 | $3.21M derived: sum of 3 quarters · filed 2015-07-30 | $5.32M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2013-05-31 | -$2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $6.00K derived: sum of 2 quarters · filed 2015-07-30 | $2.12M derived: sum of 3 quarters · filed 2015-07-30 | $2.08M 10-K · filed 2015-07-30 | ||
| 2013-02-28 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $4.89M derived: sum of 2 quarters · filed 2014-04-04 | $4.85M 10-Q · filed 2014-04-04 | $3.58M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-11-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | $2.08M 10-Q · filed 2014-01-09 | $806.00K derived: sum of 3 quarters · filed 2014-07-30 | $758.00K derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-08-31 | -$35.00K 10-Q · filed 2013-09-30 | -$1.30M derived: sum of 2 quarters · filed 2014-07-30 | -$1.35M derived: sum of 3 quarters · filed 2014-07-30 | $850.00K derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-05-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | -$1.32M derived: sum of 2 quarters · filed 2014-07-30 | $885.00K derived: sum of 3 quarters · filed 2014-07-30 | $3.09M 10-K · filed 2014-07-30 | ||
| 2012-02-29 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | $2.15M derived: sum of 2 quarters · filed 2013-03-28 | $4.36M 10-Q · filed 2013-03-28 | $5.18M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-11-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | $4.41M 10-Q · filed 2012-12-28 | $5.23M derived: sum of 3 quarters · filed 2013-07-30 | $5.06M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-08-31 | $2.21M 10-Q · filed 2012-09-28 | $3.02M derived: sum of 2 quarters · filed 2013-07-30 | $2.85M derived: sum of 3 quarters · filed 2013-07-30 | $4.08M derived: sum of 4 quarters · filed 2013-07-30 | ||
| 2011-05-31 | $817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $647.00K derived: sum of 2 quarters · filed 2013-07-30 | $1.87M derived: sum of 3 quarters · filed 2013-07-30 | $434.00K 10-K · filed 2013-07-30 | ||
| 2011-02-28 | -$170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $1.05M derived: sum of 2 quarters · filed 2012-03-30 | -$383.00K 10-Q · filed 2012-03-30 | |||
| 2010-11-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | -$213.00K 10-Q · filed 2011-12-30 | ||||
| 2010-08-31 | -$1.44M 10-Q · filed 2011-09-30 | |||||
| 2010-05-31 | -$64.00K 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |